6 Meridian’s AbbVie ABBV Stock Holding History

6 Meridian’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	$6.87M	Sell	50,752 -968	-2%	-$114K	0.5%	32
2021 Q3	$5.58M	Sell	51,720 -199	-0.4%	-$22.7K	0.44%	40
2021 Q2	$5.85M	Buy	51,919 +103	+0.2%	+$11.6K	0.46%	36
2021 Q1	$5.61M	Sell	51,816 -13,457	-21%	-$1.44M	0.48%	32
2020 Q4	$6.99M	Sell	65,273 -3,065	-4%	-$295K	0.67%	21
2020 Q3	$5.99M	Buy	68,338 +31,082	+83%	+$2.93M	0.63%	20
2020 Q2	$3.66M	Sell	37,256 -66,510	-64%	-$5.86M	0.39%	44
2020 Q1	$7.91M	Sell	103,766 -4,846	-4%	-$413K	0.83%	33
2019 Q4	$9.62M	Buy	+108,612	New	+$9.02M	0.84%	33
2019 Q3	–	Sell	-183,892	Closed	-$13.4M	–	449
2019 Q2	$13.4M	Buy	183,892 +163	+0.1%	+$12.8K	1.35%	18
2019 Q1	$14.8M	Buy	183,729 +100,177	+120%	+$8.2M	1.49%	17
2018 Q4	$7.7M	Sell	83,552 -1,681	-2%	-$148K	0.88%	30
2018 Q3	$8.06M	Buy	85,233 +26,411	+45%	+$2.5M	0.83%	34
2018 Q2	$5.45M	Buy	+58,822	New	+$5.74M	0.58%	60
2018 Q1	–	Sell	-124,464	Closed	-$12M	–	404
2017 Q4	$12M	Buy	+124,464	New	+$11.7M	1.39%	21

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

6 Meridian's ABBV Position: Q4 2021 in Review

6 Meridian reduced its AbbVie (ABBV) stake by 1.9% in Q4 2021, selling an estimated $114K and leaving 50,752 shares worth $6.87M. The position accounts for 0.5% of the portfolio, ranked #32.

6 Meridian first reported a position in ABBV in Q4 2017 and has held it in 15 quarters since. The position peaked at $14.8M in Q1 2019. 2,982 funds tracked by Wall St. Rank hold ABBV as of Q4 2021.

6 Meridian held 50,752 shares of AbbVie worth $6.87M as of Q4 2021.
6 Meridian sold 968 AbbVie shares in Q4 2021, an estimated $114K.
AbbVie made up 0.5% of 6 Meridian's portfolio in Q4 2021, its #32 holding.
6 Meridian first reported a position in AbbVie in Q4 2017 and has held it in 15 quarters since.
6 Meridian's AbbVie position peaked at $14.8M in Q1 2019.
2,982 funds tracked by Wall St. Rank held AbbVie as of Q4 2021.

Based on 6 Meridian's 13F filing for Q4 2021, filed 1 Feb 2022.